Ampio Pharma plans $9.4M placement
This article was originally published in Scrip
Executive Summary
Ampio Pharmaceuticals plans to sell 2.2 million shares of its common stock to a group of investors for $4.25 a share, and is hoping that the offering will provide gross proceeds of about $9.4 million.